Abhay Joshi, PhD MBA

Board, Chairman

Abhay Joshi currently serves as the Chief Operating Officer at Revance Therapeutics (NASDAQ: RVNC). He has 30 years of global experience as a pharmaceutical and biotechnology executive. Prior to Revance, he was the President, CEO and Director of Alvine Pharmaceuticals, a privately-held clinical stage company focused on the development of biologics targeting autoimmune and inflammatory diseases. He also served as an Executive VP and CTO at CoTherix, acquired by Actelion Ltd, in 2007. Before joining CoTherix, Dr. Joshi served as the VP of Global Technical Operations and Specialty Pharmaceuticals at Allergan to oversee the global biologics manufacturing operations for BOTOX® and its Latin America and Asia Pacific pharmaceutical operations. Dr Joshi was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2016. In addition, Dr. Joshi serves on the Board of Genyous Biomed International.